13-30461422-CTT-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_StrongPM2
The NM_002128.7(HMGB1):c.581_582delAA(p.Glu194fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 31)
Consequence
HMGB1
NM_002128.7 frameshift
NM_002128.7 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.44
Genes affected
HMGB1 (HGNC:4983): (high mobility group box 1) This gene encodes a protein that belongs to the High Mobility Group-box superfamily. The encoded non-histone, nuclear DNA-binding protein regulates transcription, and is involved in organization of DNA. This protein plays a role in several cellular processes, including inflammation, cell differentiation and tumor cell migration. Multiple pseudogenes of this gene have been identified. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.103 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMGB1 | NM_002128.7 | c.581_582delAA | p.Glu194fs | frameshift_variant | 5/5 | ENST00000341423.10 | NP_002119.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMGB1 | ENST00000341423.10 | c.581_582delAA | p.Glu194fs | frameshift_variant | 5/5 | 1 | NM_002128.7 | ENSP00000345347.5 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
HMGB1-related Developmental delay and microcephaly Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Feb 02, 2022 | The de novo heterozygous frameshift variant (p.Glu194GlyfsTer3) identified in HMGB1 has not been reported in affected individuals in the literature. The variant is absent from the gnomAD database (v3) indicating it is an extremely rare allele in the general population. The p.Glu194GlyfsTer3 variant is located in the last exon (5/5) of the HMGB1 gene. The resulting mutant mRNA is predicted to escape nonsense mediated mRNA decay and removes more than 10% of transcript. Frameshift and stop-gained variants downstream of p.Glu194GlyfsTer3 have not been reported in the literature. Based on the available evidence, the de novo Glu194GlyfsTer3 variant identified in HMGB1 is assessed as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.